High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999.
about
A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogensUnusually high prevalence of nosocomial Panton-Valentine leukocidin-positive Staphylococcus aureus isolates in Cape Verde Islands.Methicillin-resistant Staphylococcus aureus prevalence: current susceptibility patterns in TrinidadAntimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South AfricaIn vitro screening antibacterial activity of Bidens pilosa Linné and Annona crassiflora Mart. against oxacillin resistant Staphylococcus aureus (ORSA) from the aerial environment at the dental clinicMethicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007.In vitro characterization of representative clinical South African Staphylococcus aureus isolates from various clonal lineagesDiagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infectionsThe efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infectionsIn vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone.Antibiotic susceptibility of Staphylococcus aureus in suppurative lesions in Lacor Hospital, Uganda.A longitudinal analysis of methicillin-resistant Staphylococcus aureus in a Hong Kong teaching hospital.Hospital-acquired infections in a Nigerian tertiary health facility: An audit of surveillance reportsEvaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection.Community-acquired methicillin-resistant staphylococcus aureus: an emerging problem in the athletic population.Oxacillin-resistant and multidrug-resistant Staphylococcus aureus in Lima, Peru.Urinary tract infection among symptomatic outpatients visiting a tertiary hospital based in midwestern Nigeria.Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001.Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods.Cooccurrence of predominant Panton-Valentine leukocidin-positive sequence type (ST) 152 and multidrug-resistant ST 241 Staphylococcus aureus clones in Nigerian hospitals.Methicillin-resistant Staphylococcus aureus: an evolving pathogen.Contemporary methicillin-resistant Staphylococcus aureus clones in Hong Kong.Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.ANTIBIOTIC RESISTANCE PROFILING AND MICROBIOTA OF THE UPPER RESPIRATORY TRACT OF APPARENTLY HEALTHY DOGS IN IBADAN, SOUTH WEST NIGERIAIn vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone.Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic modelStaphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis.
P2860
Q24617420-92A90D7C-3B79-4CFD-84F1-88234045D267Q30357228-EE643EBA-106E-4EA0-B05A-9B9C5867B703Q33242467-E463FE67-85DD-4B6E-B25A-6005C9DF2910Q33252160-EAC0CB7A-1297-4B61-BCE0-A31E5633C3C3Q34040814-19BC569B-9648-43F8-A00A-336AC7F6C94AQ34136092-D24E03C2-0312-4F3C-ABB4-CD8557805954Q34286480-DF5A595B-517C-4652-9CED-797B912B8A02Q34352287-56AF2DC1-67BC-4FC6-92C0-1767A1602DDAQ34618696-C92A1E5C-D512-47A6-8FD1-5F1822F77D84Q34680596-795C09BB-9A85-4AC2-BB20-4B2B2B950921Q35561610-F57DF49D-9136-49A5-A567-BF69FAED9D32Q35680186-32F8B758-34BA-4F91-A439-8AFA9C4F140EQ35896250-C882AA27-F181-4DA2-B433-539C2ABE8F7AQ35913887-10C1A632-84BB-47D0-A252-B05D96409C9BQ36325494-B865C51C-D5D3-45C1-805B-25C65C046A70Q36390533-7BF6364A-8378-4B05-9AA3-E081B5272A44Q36647553-8D2D57B3-ECBF-42A4-A21D-2C21F85E6172Q37118896-606F1CEA-FCBF-4395-8418-4E91B52DB9AFQ37214008-BCD6DDEA-0906-4953-82BC-401D195C0626Q37333513-B019DB3F-C611-44CE-868F-BDD6D84A8EF8Q38171759-1FE861D3-6F07-4653-8E5E-B4AE8E59E93BQ39732185-EFA61622-DC9A-41E8-B773-167BE44F71A3Q39746366-A0A588FE-A7D4-401B-8073-CB84151E0AE7Q40851177-7969F9F8-8183-4CB4-9C0F-444A3E169FBDQ42112686-15123492-3E31-4BBF-A46D-4C0F7BDD146CQ42627265-B62DE4E2-C084-4848-9718-5B75CE88AB1DQ43831127-D915D989-601D-4DB9-B8BD-C91284C0E2C8
P2860
High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
High prevalence of oxacillin-r ...... rveillance program, 1998-1999.
@ast
High prevalence of oxacillin-r ...... rveillance program, 1998-1999.
@en
High prevalence of oxacillin-r ...... rveillance program, 1998-1999.
@nl
type
label
High prevalence of oxacillin-r ...... rveillance program, 1998-1999.
@ast
High prevalence of oxacillin-r ...... rveillance program, 1998-1999.
@en
High prevalence of oxacillin-r ...... rveillance program, 1998-1999.
@nl
prefLabel
High prevalence of oxacillin-r ...... rveillance program, 1998-1999.
@ast
High prevalence of oxacillin-r ...... rveillance program, 1998-1999.
@en
High prevalence of oxacillin-r ...... rveillance program, 1998-1999.
@nl
P2093
P2860
P921
P1476
High prevalence of oxacillin-r ...... rveillance program, 1998-1999.
@en
P2093
Jan M Bell
John D Turnidge
SENTRY APAC
P2860
P304
P356
10.1128/AAC.46.3.880-882.2002
P407
P577
2002-03-01T00:00:00Z